SynthesisFrontiers in oncology2022

Efficacy and safety of immune checkpoint inhibitors-combined antiangiogenic drugs in the treatment of hepatocellular carcinoma: A systematic review and meta analysis.

Yu Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.